# Financial Toxicity and Quality of Life in Patients With TGCT

> **NCT04531709** · — · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 24 (actual)

## Conditions studied

- Testicular Neoplasm

## Interventions

- **OTHER:** Comprehensive Score for financial toxicity (COST)
- **OTHER:** Functional Assessment of Cancer Therapy: General (FACT-G)
- **OTHER:** EORTC QLQ C-30
- **OTHER:** EORTC QLQ-TC26.

## Key facts

- **NCT ID:** NCT04531709
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2025-02-04
- **Final completion:** 2025-02-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04531709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04531709, "Financial Toxicity and Quality of Life in Patients With TGCT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04531709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*